A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories, and Dr. Reddy’s Laboratories
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
During Q1FY26, the company incurred Capex of ~Rs. 48.5 crores mainly towards capacity expansion, backward integration and finished formulation R&D
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
Subscribe To Our Newsletter & Stay Updated
